Medtronic buys neurological instruments leader
This article was originally published in Clinica
Medtronic is to bolster its neurosurgical business with the acquisition of Midas Rex, a privately-owned company which produces high-speed, powered neurological instruments, for an undisclosed amount. The Fort Worth, Texas-based company expects to generate revenues of +ACQ-55 million in 1998.
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.